I. Executive Summary
4-Amino-3-hydroxybenzoic acid, CAS 2374-03-0, is an aminohydroxybenzoic acid isomer with molecular formula C7H7NO3 and molecular weight 153.14, supplied as an off-white to light tan crystalline powder. It carries three functional groups in one small aromatic unit — a carboxylic acid, a phenolic hydroxyl, and an aniline-type primary amine — which makes it simultaneously a versatile difunctional monomer, a diazo-coupling component, and a positional isomer of the para-aminosalicylic acid structural class. It is supplied strictly as an industrial intermediate for further chemical synthesis and not as a finished product of any kind.
Commercial interest rests on three end uses. As a pharmaceutical intermediate it provides the aminohydroxybenzoic substitution pattern used in anti-tuberculosis chemistry related to the para-aminosalicylic acid class, and it serves more broadly as a rigid, functionalised aromatic building block. As a dye and pigment intermediate it acts as a diazo component and coupling component for azo chromophores. As a polymer monomer, its ortho-aminophenol relationship supports the synthesis of benzoxazole-containing high-performance polymers, where an AB-type monomer avoids the stoichiometry problems of a two-component system.
Because the molecule is a primary aromatic amine, it sits inside one of the most scrutinised chemical classes in modern quality regulation. Aromatic amines are a recognised structural alert for mutagenicity, so pharmaceutical customers expect an ICH M7 assessment covering the substance itself and its related aromatic amine impurities, while nitro precursors and positional isomers must be controlled to defined limits. Combined with dust-exposure management and protection from oxidation, these requirements make documentation and packaging, rather than price, the decisive variables in supplier selection.
II. Product Deep Dive: Molecular Mechanisms and Production Evolution
2.1 Physicochemical Properties and Mechanisms
The three substituents generate a strongly interacting electronic system: the phenol is acidic, the aniline nitrogen is nucleophilic and readily diazotised, and the carboxylic acid permits salt formation, esterification, and amidation. Solubility is poor in neutral water but improves in acid or base through salt formation, and it is stable when dry and protected from light but browns on prolonged air exposure, because the aminophenol motif oxidises readily.
- Ortho-aminophenol reactivity: The amine and phenol occupy adjacent positions, so the molecule can cyclise with carbonyl partners to form benzoxazole rings, chelate metal ions through the nitrogen and oxygen pair, and undergo oxidative coupling. This bifunctionality is the reason it is valued as an AB-type monomer for benzoxazole polymers, where a single monomer carries both complementary groups and therefore gives inherently balanced stoichiometry.
- Diazotisation and azo coupling: The primary aromatic amine is diazotised under standard nitrous acid conditions and the resulting diazonium salt couples with phenols, naphthols, and aromatic amines to give azo chromophores, while the ring's own phenolic hydroxyl can itself act as a coupling site. This dual behaviour is why the substance appears in azo dye and pigment synthesis, and why residual nitrite and diazonium chemistry must be fully quenched and controlled in manufacture.
2.2 Synthesis and Manufacturing Technologies
Production follows established aromatic substitution logic, and the two practised route classes differ mainly in whether the amine is introduced by reduction of a nitro group or carried through from an aminated precursor.
- Nitration-reduction sequence: A hydroxybenzoic acid precursor is nitrated regioselectively to install the nitro group at the position that becomes the amine, and the nitro intermediate is then reduced by catalytic hydrogenation or by chemical reduction to give the target amine. The route benefits from mature, scalable unit operations and inexpensive reagents, but regioselectivity is never absolute: isomeric nitro acids are formed and must be removed, and any nitro compound carried through becomes a genotoxic-impurity concern under ICH M7.
- Hydroxylation and carboxylation routes: Alternative approaches hydroxylate an aminobenzoic acid precursor, or build the carboxyl group onto an aminophenol substrate through carboxylation chemistry, followed by protection and deprotection steps where needed. These routes can give better regiochemical control and avoid nitro intermediates entirely, which is attractive for pharmaceutical customers, but they are longer and typically more expensive. Finishing in all cases requires controlled crystallisation, washing to remove inorganic salts, and drying under inert conditions to protect the aminophenol from oxidation.
2.3 Core Application Matrix
- Pharmaceutical intermediate: The aminohydroxybenzoic acid pattern is used in anti-tuberculosis chemistry related to the para-aminosalicylic acid class and as a functionalised aromatic scaffold in broader medicinal programmes. Buyers in this tier require ICH Q7-aligned documentation, an ICH M7 mutagenic-impurity assessment, and defined limits for nitro and isomeric impurities.
- Dye and pigment intermediate: As a diazotisable amine and a coupling component, the substance supports azo dye and pigment manufacture for textile, ink, and coating applications. Specifications here emphasise diazo value, shade-relevant related substances, and insoluble matter rather than pharmaceutical-style impurity dossiers.
- Polymer monomer: The ortho-aminophenol arrangement is condensed with carboxylic acid derivatives to form benzoxazole rings, supporting high-performance polymer programmes where thermal stability and rigidity are required. This tier demands very high purity and low metal content, because transition metals and ionic residues interfere with polymerisation and with the properties of the final polymer.
III. Global Market Supply-Demand Landscape and Export Trends
3.1 Demand Drivers and Market Shifts
Demand is anchored in three relatively independent drivers. Tuberculosis programmes and generic anti-tuberculosis supply chains sustain pharmaceutical enquiry, particularly through Indian and Chinese API producers. Azo pigment and specialty dye demand follows textile, ink, and coating production and is cyclical and price-sensitive. High-performance polymer programmes generate small but technically demanding volumes where purity, not price, governs supplier choice.
3.2 Capacity Distribution and Export Flows
Chinese producers in Zhejiang, Jiangsu, and Shandong dominate merchant supply, operating nitration, hydrogenation, and crystallisation assets with ready access to aromatic feedstock and serving both domestic dye producers and export customers in Europe, India, Japan, and the Americas. Indian manufacturers in Gujarat, Maharashtra, and Hyderabad focus on pharmaceutical-oriented supply with strengthening regulatory documentation, while Japanese, Korean, and Western European suppliers hold niche positions in high-purity and polymer-grade material.
3.3 Market Bifurcation and Pricing Dynamics
The market divides into dye-grade material, priced against aromatic feedstock and acid and hydrogenation costs and contestable on price, and pharmaceutical- or polymer-grade material, priced against documentation and impurity control. The latter carries a substantial premium because the analytical work, the mutagenic-impurity assessment, and the controlled handling required for aromatic amines are genuine cost drivers. Volatility follows benzene-derivative feedstock economics, hydrogenation catalyst costs, and environmental inspection cycles affecting nitration capacity.
IV. In-depth Analysis of Global Compliance and Regulatory Barriers
Aromatic amines attract regulatory attention disproportionate to their tonnage. Beyond general chemical-control obligations, buyers must address mutagenic-impurity expectations, occupational exposure to dust, and, for dye applications, the downstream restrictions that apply to aromatic amines released from azo colorants.
4.1 European Market: REACH, CLP, and Sector-Specific Directives
- REACH registration and CLP classification: Substance identity, tonnage band, and registration status must be verified in the ECHA database before contracting, with the importer or only representative holding a registration covering the intended volume. Classification must be read from the C&L Inventory and supplier safety data sheet; aminophenol-type substances are commonly notified for skin and eye irritation and for specific target organ effects, and no classification should be assumed in the absence of a harmonised entry.
- Azo colorant restrictions and downstream article controls: Where the substance is used to manufacture azo colorants, downstream users must verify that finished colorants do not release any of the aromatic amines restricted under REACH Annex XVII for textile and leather articles, and must comply with associated test-method and labelling obligations. Buyers should therefore obtain cleavable-amine statements from suppliers, because a restriction triggered downstream can invalidate an otherwise compliant intermediate purchase.
4.2 North American Market: TSCA, EPA, and FDA Regulations
- TSCA inventory and EPA obligations: The substance must be active on the TSCA inventory for the intended commercial activity, and importers must satisfy EPA reporting and Section 13 import certification. Manufacturers should confirm that nitration and hydrogenation operations, nitrous oxide emissions, and amine-containing wastewater are covered by applicable federal, state, and provincial permits.
- FDA-facing documentation: Where the material supports a drug substance, customers require supplier documentation covering starting-material justification, impurity profiles, and container-closure statements for the relevant submission, potentially supported by a drug master file or equivalent confidential dossier. The intermediate itself is not approved or evaluated by the agency, and no therapeutic claim attaches to it.
4.3 The Critical Hurdle: Quality Control and Safety Limits
Compliance Warning: The specification must be written around the aromatic amine risk, not around assay alone. Required parameters include: identity by NMR or IR against a reference spectrum; assay by HPLC or titration with a validated method; individual and total related substances with explicit limits for positional isomers generated during nitration or hydroxylation; specific limits for residual nitro intermediates and other aromatic amine impurities, justified by an ICH M7 assessment using either a compound-specific acceptable intake derived from carcinogenicity data or the threshold of toxicological concern for a lifetime or less-than-lifetime exposure; residual solvents by ICH Q3C class; elemental impurities screened against ICH Q3D limits; water by Karl Fischer; and dust-characterisation and appearance checks, since oxidation darkens the powder and signals degradation. Where a nitration route is used, buyers should require documented evidence of nitro-compound purge, including purge-factor calculations or lot data, rather than relying on a general statement of compliance.
V. Green Trade Barriers and ESG in Manufacturing
Nitration and catalytic hydrogenation define the environmental profile of this molecule, and both are regulated activities with distinctive emissions and effluent signatures that customers increasingly audit during supplier qualification.
5.1 Carbon Footprint and Circular Economy
Mixed-acid nitration is exothermic and requires refrigeration and quench capacity, while hydrogenation consumes hydrogen and precious-metal catalyst and demands energy for separation and drying. Producers reduce footprint through heat recovery from nitration, catalyst recovery and refining, hydrogen generated or sourced with lower carbon intensity, and solvent and acid recovery loops. European customers increasingly request product-level carbon-footprint data aligned with ISO 14067 or the GHG Protocol Product Standard.
5.2 Sustainable Sourcing and Traceability
Traceability expectations cover aromatic feedstock provenance, precious-metal catalyst custody, amine-containing wastewater treatment, and absence of SVHC-relevant contaminants. ISO 9001, ISO 14001, and ISO 45001 certification, Responsible Care or equivalent participation, and third-party ESG ratings such as EcoVadis are becoming standard pre-qualification gates, alongside occupational-hygiene evidence for aromatic amine handling, including health surveillance and exposure monitoring records where corporate policy requires them.
VI. Supply Chain Resilience and Export Logistics
Handling risk is dominated by dust and oxidation. The powder is respirable, the aromatic amine class demands containment discipline, and the aminophenol functionality darkens on exposure to air and light, so packaging and transfer practice determine whether a compliant lot arrives in specification.
6.1 Packaging Standards and Moisture/Contamination Control
- Light-proof, oxidation-protected packing: Export packing should use an opaque or foil-laminate inner liner, heat-sealed inside a fibre or UN-approved drum, typically 25 kg net, ideally closed under nitrogen with an oxygen absorber or desiccant. Dark storage and avoidance of prolonged headspace exposure are essential, because oxidation darkens the material and generates related substances that complicate pharmaceutical acceptance. Certificates of analysis should therefore record appearance or colour alongside assay.
- Dust control and occupational exposure: Transfer operations require closed charging, local exhaust ventilation, and dust suppression, with operators using gloves, eye protection, and respiratory protection selected against the occupational exposure limit in the safety data sheet. Because aromatic amines may be absorbed through the skin, gloves and hygiene controls are as important as respiratory protection, and dedicated equipment prevents cross-contamination with other aromatic intermediates.
6.2 Dangerous Goods Identification and Transit Protocols
Transport status must be confirmed against Section 14 of the current safety data sheet and the notifying manufacturer's classification; aminobenzoic acid derivatives are frequently shipped as non-hazardous for transport, but a notified irritation or aquatic classification changes the shipping description, labelling, and marking requirements under IMDG, ADR, RID, and IATA. Documentation should always accompany the consignment: safety data sheet in the destination language, certificate of analysis with lot-specific related-substance and residual-nitro values, and a retained sample held under the same conditions as the delivered lot.
VII. Enterprise Global Expansion Strategy Guide
Buyers who succeed with this molecule treat the mutagenic-impurity question as a qualification gate rather than paperwork. The following sequence reflects best practice among pharmaceutical, dye, and polymer customers.
- Qualify the ICH M7 package before the price: Require a written mutagenic-impurity assessment identifying the substance and each aromatic amine and nitro-related impurity, with acceptable intakes derived from compound-specific data or from the threshold of toxicological concern, and with documented purge evidence where a nitration route is used. A supplier unable to provide this will eventually fail a regulatory inspection, regardless of how attractive the price.
- Specify isomers, nitro residues, and colour explicitly: Write positional isomer limits, residual nitro compound limits, elemental impurities, residual solvents, water, and appearance into the purchase specification, and require lot chromatograms. For dye applications add diazo value and insoluble matter, and for polymer applications add metal-ion limits.
- Dual-source and monitor the restriction lists: Maintain one Chinese volume supplier and one Indian or Japanese documentation-strong supplier, and assign ownership for tracking ECHA and member-state action on aromatic amines, REACH Annex XVII azo provisions, and TSCA developments. Change-control clauses should require notification of any route, catalyst, or site change, since such changes alter the impurity profile underpinning the assessment.
VIII. Conclusion
4-Amino-3-hydroxybenzoic acid is a compact trifunctional aromatic whose value lies in the density of chemistry it offers: a diazotisable amine, an acidic phenol, and a carboxyl group arranged for cyclisation into benzoxazole structures. Its markets span anti-tuberculosis-related pharmaceutical chemistry, azo dyes and pigments, and high-performance polymer monomers, and each market demands a different specification. Its risk lies in the same aromatic amine functionality that makes it useful, because that class carries mutagenicity-alert expectations and occupational-handling obligations.
The sourcing agenda follows directly: require an ICH M7 assessment with documented nitro purge evidence, specify isomers and nitro residues explicitly, insist on opaque nitrogen-packed drums with dust-controlled handling, and dual-source across at least two producing regions. Organisations that integrate mutagenic-impurity control, packaging integrity, and regulatory monitoring into a single qualification programme will secure dependable supply of this versatile and tightly regulated intermediate.
IX. Industry Resource Connection and Supplier Ecosystem
Powered by Guidechem
This white paper is exclusively compiled by the Guidechem Intelligence Team based on global customs data, regulatory databases, and industry research. Guidechem is a leading global B2B chemical platform, dedicated to connecting global buyers with verified, high-quality manufacturers.
Relying on Guidechem's extensive global database, we have mapped the core participants in the current global 4-Amino-3-hydroxybenzoic acid supply chain:
- China — nitration and hydrogenation cluster: Producers in Zhejiang, Jiangsu, and Shandong operate integrated nitration, catalytic hydrogenation, and crystallisation assets with ready aromatic feedstock access, supplying domestic dye manufacturers and export customers across Europe, India, Japan, and the Americas. Their advantage is scale and cost, with improving capability in impurity profiling and REACH dossier support.
- India — pharmaceutical-oriented supply: Manufacturers in Gujarat, Maharashtra, and Hyderabad serve generic API value chains tied to anti-tuberculosis programmes, providing GMP-style batch records, impurity profiles, mutagenic-impurity assessments, and change-control commitments in English. Their strength is regulatory documentation and audit readiness rather than commodity price.
- European Union, Japan, and Korea — high-purity and polymer grade: Specialty manufacturers and reagent houses in Germany, Switzerland, Japan, and Korea supply tightly specified material for polymer monomer and pharmaceutical development, with established REACH registrations, full analytical data, and short lead times. They price at a premium justified by purity, metal-ion control, and documentation depth.
Disclaimer: The content of this white paper is compiled based on public market data and regulatory information available as of 2026. Global chemical regulations are subject to dynamic adjustments. In actual export operations, enterprises must consult professional regulatory advisors or relevant competent authorities to obtain the latest compliance guidance.